{
    "clinical_study": {
        "@rank": "102568", 
        "arm_group": [
            {
                "arm_group_label": "Chloroprep and biopatch", 
                "arm_group_type": "No Intervention", 
                "description": "Both arms are cleaned with chloroprep and a biopatch is placed on each arm."
            }, 
            {
                "arm_group_label": "Methylene blue and light treatment", 
                "arm_group_type": "Experimental", 
                "description": "Methylene blue and light treatment for 17 minutes are done twice over 1 week intervals."
            }
        ], 
        "brief_summary": {
            "textblock": "We are evaluating the effect of methylene blue and visible light activation on the\n      microbiome of the skin."
        }, 
        "brief_title": "PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Healthy Volunteers.", 
        "completion_date": {
            "#text": "July 2013", 
            "@type": "Actual"
        }, 
        "condition": "Light; Therapy, Complications", 
        "detailed_description": {
            "textblock": "Antiseptics are routinely utilized to prevent infections of vascular catheters. We are\n      evaluating the addition of methylene blue and light activation on skin to determine whether\n      this inexpensive and non-toxic treatment can decrease skin pathogens and prevent blood\n      stream infections of long-term vascular catheters. This is a pilot study of normal\n      volunteers to determine the effect on the microbiome of the addition of methylene blue and\n      light activation on antiseptic-treated skin."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Normal individuals without skin problems\n\n        Exclusion Criteria:\n\n          -  Smokers\n\n          -  Diabetics\n\n          -  Atopic dermatitis\n\n          -  G-6-PD deficiency\n\n          -  Eczema\n\n          -  Other skin conditions\n\n          -  Allergies to methylene blue or chlorhexadine"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "60 Years", 
            "minimum_age": "21 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "November 5, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01981460", 
            "org_study_id": "2012P-002692"
        }, 
        "intervention": {
            "arm_group_label": "Methylene blue and light treatment", 
            "description": "Methylene blue and light treatment for 17 minutes are done twice over 1 week intervals.", 
            "intervention_name": "Methylene blue and light treatment", 
            "intervention_type": "Procedure"
        }, 
        "intervention_browse": {
            "mesh_term": "Methylene Blue"
        }, 
        "is_fda_regulated": "Yes", 
        "is_section_801": "Yes", 
        "lastchanged_date": "November 8, 2013", 
        "number_of_arms": "2", 
        "official_title": "PhotoDynamic Therapy for Line Infection Prevention (PLIP): Pilot Study on Normal Volunteers", 
        "overall_official": {
            "affiliation": "MGH", 
            "last_name": "Jeanine Wiener-Kronish, MD", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United States: Institutional Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "We compared the two arms of each subject --one arm treated with chloraprep and a biopatch [routine treatment of skin] to the routine treatment with the addition of methylene blue spray and light activation. The microbiome of both skin areas were assessed before and after the routine treatment and the treatment with the addition of methylene blue therapy;", 
            "measure": "Evaluation of the skin microbiome after methylene blue treatment", 
            "safety_issue": "No", 
            "time_frame": "1 week"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01981460"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Massachusetts General Hospital", 
            "investigator_full_name": "Jeanine Wiener-Kronish", 
            "investigator_title": "Chief of Anesthesia", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "source": "Massachusetts General Hospital", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Massachusetts General Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "May 2013", 
        "study_design": "Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}